FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Edge Pharma Methotrexate Recall

Methotrexate, USP Sterile Solution for Injection, Preservative Free 125mg/5ml (25mg/ml)…

Edge Pharma, LLC · Colchester, VT

Risk level
Class II
Reported by FDA
Jan 20, 2021
Recall ID
D-0226-2021
Check your lot numberHow we source this data

Summary

Edge Pharma recalled Methotrexate starting Mar 19, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0226-2021 on Jan 20, 2021. Reason: Lack of Assurance of Sterility; the media used to conduct post-compounding sterility testing for the Methotrexate product was expired. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility; the media used to conduct post-compounding sterility testing for the Methotrexate product was expired.

Product description

Methotrexate, USP Sterile Solution for Injection, Preservative Free 125mg/5ml (25mg/ml), 5 mL per syringe, Rx Only, SYRINGE FOR IM INJECTION, Edge Pharma, LLC 856 Hercules Dr. Colchester, VT 05446 Customer Service (USA) 1-802-992-1178, Barcode 0544650505

Lot numbers, UPCs & expiration codes

Lot# 01-2020-28@10

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0226-2021
Classification
Class II
Status
Terminated
Recall initiated
Mar 19, 2020
FDA report date
Jan 20, 2021
Quantity
71 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
Edge Pharma, LLC

Original FDA data

Every field from FDA enforcement report D-0226-2021, exactly as published.

Show all FDA fields
City
Colchester
State
VT
Status
Terminated
Country
United States
Event ID
87115
Address
856 Hercules Dr
Code information
Lot# 01-2020-28@10
Postal code
05446-8014
Report date
Jan 20, 2021
Product type
Drugs
Recall number
D-0226-2021
Classification
Class II
Recalling firm
Edge Pharma, LLC
Product quantity
71 syringes
Termination date
Jun 7, 2023
Reason for recall
Lack of Assurance of Sterility; the media used to conduct post-compounding sterility testing for the Methotrexate product was expired.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Methotrexate, USP Sterile Solution for Injection, Preservative Free 125mg/5ml (25mg/ml), 5 mL per syringe, Rx Only, SYRINGE FOR IM INJECTION, Edge Pharma, LLC 856 Hercules Dr. Colchester, VT 05446 Customer Service (USA) 1-802-992-1178, Barcode 0544650505
Distribution pattern
Nationwide
Recall initiation date
Mar 19, 2020
Initial firm notification
Letter
Center classification date
Jan 12, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0226-2021, published Jan 20, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls